204 related articles for article (PubMed ID: 21142151)
41. The specific and rapid labeling of cell surface proteins with recombinant FKBP-fused fluorescent proteins.
Zhang X; Deng Y; Chang H; Ji C; Zhang M; Peng J; Xu T; Xu P
Protein Cell; 2014 Oct; 5(10):800-3. PubMed ID: 25109944
[No Abstract] [Full Text] [Related]
42. Regulating cell surface glycosylation with a small-molecule switch.
Dube DH; de Graffenried CL; Kohler JJ
Methods Enzymol; 2006; 415():213-29. PubMed ID: 17116477
[TBL] [Abstract][Full Text] [Related]
43. Novel fusion protein approach for efficient high-throughput screening of small molecule-mediating protein-protein interactions in cells and living animals.
Paulmurugan R; Gambhir SS
Cancer Res; 2005 Aug; 65(16):7413-20. PubMed ID: 16103094
[TBL] [Abstract][Full Text] [Related]
44. Solution structure of the Legionella pneumophila Mip-rapamycin complex.
Ceymann A; Horstmann M; Ehses P; Schweimer K; Paschke AK; Steinert M; Faber C
BMC Struct Biol; 2008 Mar; 8():17. PubMed ID: 18366641
[TBL] [Abstract][Full Text] [Related]
45. Reversible Chemical Dimerization by rCD1.
Schifferer M; Feng S; Stein F; Schultz C
Methods Enzymol; 2017; 583():173-195. PubMed ID: 28063490
[TBL] [Abstract][Full Text] [Related]
46. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
Sigal NH; Dumont FJ
Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
[TBL] [Abstract][Full Text] [Related]
47. Rapamycin-inspired macrocycles with new target specificity.
Guo Z; Hong SY; Wang J; Rehan S; Liu W; Peng H; Das M; Li W; Bhat S; Peiffer B; Ullman BR; Tse CM; Tarmakova Z; Schiene-Fischer C; Fischer G; Coe I; Paavilainen VO; Sun Z; Liu JO
Nat Chem; 2019 Mar; 11(3):254-263. PubMed ID: 30532015
[TBL] [Abstract][Full Text] [Related]
48. ER trapping reveals Golgi enzymes continually revisit the ER through a recycling pathway that controls Golgi organization.
Sengupta P; Satpute-Krishnan P; Seo AY; Burnette DT; Patterson GH; Lippincott-Schwartz J
Proc Natl Acad Sci U S A; 2015 Dec; 112(49):E6752-61. PubMed ID: 26598700
[TBL] [Abstract][Full Text] [Related]
49. FK506 and rapamycin neuroprotect erection and involve different immunophilins in a rat model of cavernous nerve injury.
Lagoda G; Sezen SF; Burnett AL
J Sex Med; 2009 Jul; 6(7):1914-23. PubMed ID: 19453873
[TBL] [Abstract][Full Text] [Related]
50. P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration.
Hernández-Negrete I; Carretero-Ortega J; Rosenfeldt H; Hernández-García R; Calderón-Salinas JV; Reyes-Cruz G; Gutkind JS; Vázquez-Prado J
J Biol Chem; 2007 Aug; 282(32):23708-15. PubMed ID: 17565979
[TBL] [Abstract][Full Text] [Related]
51. Crystal structure of the FK506 binding domain of human FKBP25 in complex with FK506.
Prakash A; Rajan S; Yoon HS
Protein Sci; 2016 Apr; 25(4):905-10. PubMed ID: 26749369
[TBL] [Abstract][Full Text] [Related]
52. An inducible translocation strategy to rapidly activate and inhibit small GTPase signaling pathways.
Inoue T; Heo WD; Grimley JS; Wandless TJ; Meyer T
Nat Methods; 2005 Jun; 2(6):415-8. PubMed ID: 15908919
[TBL] [Abstract][Full Text] [Related]
53. Modelling cell polarization driven by synthetic spatially graded Rac activation.
Holmes WR; Lin B; Levchenko A; Edelstein-Keshet L
PLoS Comput Biol; 2012; 8(6):e1002366. PubMed ID: 22737059
[TBL] [Abstract][Full Text] [Related]
54. Berunda Polypeptides: Multi-Headed Fusion Proteins Promote Subcutaneous Administration of Rapamycin to Breast Cancer
Dhandhukia JP; Li Z; Peddi S; Kakan S; Mehta A; Tyrpak D; Despanie J; MacKay JA
Theranostics; 2017; 7(16):3856-3872. PubMed ID: 29109782
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases.
Dunford JE; Rogers MJ; Ebetino FH; Phipps RJ; Coxon FP
J Bone Miner Res; 2006 May; 21(5):684-94. PubMed ID: 16734383
[TBL] [Abstract][Full Text] [Related]
56. Photocleavable dimerizer for the rapid reversal of molecular trap antagonists.
Ahmed S; Xie J; Horne D; Williams JC
J Biol Chem; 2014 Feb; 289(8):4546-52. PubMed ID: 24421317
[TBL] [Abstract][Full Text] [Related]
57. Chemically induced and light-independent cryptochrome photoreceptor activation.
Rosenfeldt G; Viana RM; Mootz HD; von Arnim AG; Batschauer A
Mol Plant; 2008 Jan; 1(1):4-14. PubMed ID: 20031911
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and application of light-switchable arylazopyrazole rapamycin analogs.
Courtney TM; Horst TJ; Hankinson CP; Deiters A
Org Biomol Chem; 2019 Sep; 17(36):8348-8353. PubMed ID: 31469140
[TBL] [Abstract][Full Text] [Related]
59. FK506 binding proteins as targets in anticancer therapy.
Romano S; Di Pace A; Sorrentino A; Bisogni R; Sivero L; Romano MF
Anticancer Agents Med Chem; 2010 Nov; 10(9):651-6. PubMed ID: 21182472
[TBL] [Abstract][Full Text] [Related]
60. Engineered Extracellular Vesicles with Compound-Induced Cargo Delivery to Solid Tumors.
Kim R; Kim JH
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
